Endnote export

 

%T Pricing and Patents of HIV/AIDS Drugs in Developing Countries
%A Borrell, Joan-Ramon
%J Applied Economics
%N 4
%P 505-518
%V 39
%D 2007
%= 2011-04-01T03:12:00Z
%~ http://www.peerproject.eu/
%> https://nbn-resolving.org/urn:nbn:de:0168-ssoar-239489
%X This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices are correlated to per capita income levels, and that drug firms follow a skimming strategy when pricing new HIV/AIDS drugs. That is, there is across country and intertemporal price discrimination in the global drug markets.
%G en
%9 journal article
%W GESIS - http://www.gesis.org
%~ SSOAR - http://www.ssoar.info